Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Dermata Therapeutics, Inc.
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | | 10-Q | 10-Q | 10-K | S-1 | 10-Q |
| Assets |
| Cash and equivalents | 8.4 | 8.8 | | 10.6 | 8.2 | 10.8 | 12.6 | 0.4 |
| Other current assets | 0.3 | 0.5 | | 0.4 | 0.9 | 0.8 | 1.1 | 0.7 |
| Total current assets | 8.7 | 9.3 | | 11.0 | 9.0 | 11.6 | 13.7 | 1.1 |
| Total assets | 8.7 | 9.3 | | 11.0 | 9.0 | 11.6 | 13.7 | 1.1 |
| |
| Accounts payable | 0.4 | 0.5 | | 0.6 | 0.7 | 0.5 | 0.8 | 0.9 |
| Accrued expenses | 0.2 | 0.7 | | 0.8 | 0.5 | 1.0 | 0.4 | 0.6 |
| Short-term debt | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | | | | | | | | 0.2 |
| Total current liabilities | 0.7 | 1.2 | | 1.4 | 1.2 | 1.5 | 1.2 | 1.6 |
| Total liabilities | 0.7 | 1.2 | | 1.4 | 1.2 | 1.5 | 1.2 | 1.6 |
| |
| Shareholders' equity [+] | 8.0 | 8.1 | | 9.7 | 7.9 | 10.1 | 12.5 | -0.5 |
| Paid-in capital | 57.6 | 55.9 | | 51.2 | 46.6 | 46.1 | 45.9 | 31.2 |
| Retained earnings | -49.5 | -47.8 | | -41.5 | -38.8 | -36.0 | -33.4 | -31.7 |
| Tangible shareholders' equity | 8.0 | 8.1 | | 9.7 | 7.9 | 10.1 | 12.5 | -0.5 |
|